Literature DB >> 7028554

Oral glucose tolerance, insulin and gastric inhibitory polypeptide secretion in patients recovered from acute myocardial infarction.

S Larsen, K B Lauritsen, I Christiansen.   

Abstract

Ten male patients, recovered from acute myocardial infarction, and ten control subjects were investigated by a 50 g glucose tolerance test. All patients and control subjects had normal glucose tolerance, but the patients had increased fasting and integrated insulin response to oral glucose. Fasting gastric inhibitory polypeptide concentrations and integrated gastric inhibitory polypeptide response were normal in the patients. The exaggerated insulin secretion in patients recovered from myocardial infarction does not seem to be caused by increased secretion of gastric inhibitory polypeptide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7028554     DOI: 10.1007/bf00252660

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION.

Authors:  N PETERS; C N HALES
Journal:  Lancet       Date:  1965-05-29       Impact factor: 79.321

2.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

3.  Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease.

Authors:  M Tzagournis; R Chiles; J M Ryan; T G Skillman
Journal:  Circulation       Date:  1968-12       Impact factor: 29.690

4.  The association between plasma GIP and insulin after oral glucose.

Authors:  K B Lauritsen; A J Moody
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

5.  Diabetes and atherosclerosis--the role of insulin.

Authors:  R W Stout
Journal:  Diabetologia       Date:  1979-03       Impact factor: 10.122

6.  Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide.

Authors:  E A Nikkilä; T A Miettinen; M R Vesenne; R Pelkonen
Journal:  Lancet       Date:  1965-09-11       Impact factor: 79.321

7.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 8.  Carbohydrate metabolism in cardiovascular disease.

Authors:  L H Opie; W A Stubbs
Journal:  Clin Endocrinol Metab       Date:  1976-11

9.  Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.

Authors:  W Creutzfeldt; M Talaulicar; R Ebert; B Willms
Journal:  Diabetes       Date:  1980-02       Impact factor: 9.461

10.  Coronary arteriographic findings in patients with previous acute myocardial infarction.

Authors:  J F Hansen
Journal:  Acta Med Scand       Date:  1978
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.